203 related articles for article (PubMed ID: 17466115)
21. Lactoferrampin: a novel antimicrobial peptide in the N1-domain of bovine lactoferrin.
van der Kraan MI; Groenink J; Nazmi K; Veerman EC; Bolscher JG; Nieuw Amerongen AV
Peptides; 2004 Feb; 25(2):177-83. PubMed ID: 15062998
[TBL] [Abstract][Full Text] [Related]
22. Synthetic porcine lactoferricin with a 20-residue peptide exhibits antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Candida albicans.
Chen HL; Yen CC; Lu CY; Yu CH; Chen CM
J Agric Food Chem; 2006 May; 54(9):3277-82. PubMed ID: 16637685
[TBL] [Abstract][Full Text] [Related]
23. High-level expression, purification and antibacterial activity of bovine lactoferricin and lactoferrampin in Photorhabdus luminescens.
Tang Z; Zhang Y; Stewart AF; Geng M; Tang X; Tu Q; Yin Y
Protein Expr Purif; 2010 Oct; 73(2):132-9. PubMed ID: 20510367
[TBL] [Abstract][Full Text] [Related]
24. A novel carrier molecule for high-level expression of peptide antibiotics in Escherichia coli.
Rao XC; Li S; Hu JC; Jin XL; Hu XM; Huang JJ; Chen ZJ; Zhu JM; Hu FQ
Protein Expr Purif; 2004 Jul; 36(1):11-8. PubMed ID: 15177279
[TBL] [Abstract][Full Text] [Related]
25. The role of tryptophan in the antibacterial activity of a 15-residue bovine lactoferricin peptide.
Haug BE; Svendsen JS
J Pept Sci; 2001 Apr; 7(4):190-6. PubMed ID: 11354462
[TBL] [Abstract][Full Text] [Related]
26. Expression, purification and in vitro N-myristoylation of human Src N-terminal region.
Ma HH; Yang L; Li BL
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jan; 35(1):13-7. PubMed ID: 12518222
[TBL] [Abstract][Full Text] [Related]
27. The effects of charge and lipophilicity on the antibacterial activity of undecapeptides derived from bovine lactoferricin.
Strøm MB; Rekdal O; Svendsen JS
J Pept Sci; 2002 Jan; 8(1):36-43. PubMed ID: 11831560
[TBL] [Abstract][Full Text] [Related]
28. [Cloning of human migfilin N-terminal domain and preparation of anti-migfilin polyclonal antibody].
Gong W; Li J; Wang YL; Nan QZ; Jiang B; Zhang HQ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):915-8. PubMed ID: 18583227
[TBL] [Abstract][Full Text] [Related]
29. Anti-complement effects of lactoferrin-derived peptides.
Samuelsen Ø; Haukland HH; Ulvatne H; Vorland LH
FEMS Immunol Med Microbiol; 2004 Jun; 41(2):141-8. PubMed ID: 15145458
[TBL] [Abstract][Full Text] [Related]
30. Prokaryotic expression of bovine lactoferrin deletion mutants that bind to the Ca2+-dependent lactoferrin receptor on isolated rat hepatocytes.
Sitaram MP; Moloney B; McAbee DD
Protein Expr Purif; 1998 Nov; 14(2):229-36. PubMed ID: 9790885
[TBL] [Abstract][Full Text] [Related]
31. Prediction of antibiotic activity and synthesis of new pentadecapeptides based on lactoferricins.
Lejon T; Stiberg T; Strøm MB; Svendsen JS
J Pept Sci; 2004 Jun; 10(6):329-35. PubMed ID: 15214437
[TBL] [Abstract][Full Text] [Related]
32. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of a 2-arylsulphonylated tryptophan: the antibacterial activity of bovine lactoferricin peptides containing Trp(2-Pmc).
Haug BE; Andersen J; Rekdal O; Svendsen JS
J Pept Sci; 2002 Jul; 8(7):307-13. PubMed ID: 12148780
[TBL] [Abstract][Full Text] [Related]
34. A C-terminal glycine suppresses production of pleurocidin as a fusion peptide in Escherichia coli.
Bryksa BC; MacDonald LD; Patrzykat A; Douglas SE; Mattatall NR
Protein Expr Purif; 2006 Jan; 45(1):88-98. PubMed ID: 15935695
[TBL] [Abstract][Full Text] [Related]
35. A spontaneous direct repeat deletion in the pGEX fusion vector decreases the expression level of recombinant proteins in Escherichia coli.
Borgi I; Gargouri A
Protein Expr Purif; 2008 Jul; 60(1):15-9. PubMed ID: 18434194
[TBL] [Abstract][Full Text] [Related]
36. Enterokinase cleavage of fusion proteins for preparation of recombinant human parathyroid hormone 1-34.
Xiu ZY; Zhou HY; Yu Y; Dai JF; Chen CQ
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Jul; 34(4):469-74. PubMed ID: 12098770
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of mastitic bacteria by bovine milk apo-lactoferrin evaluated by in vitro microassay of bacterial growth.
Nonnecke BJ; Smith KL
J Dairy Sci; 1984 Mar; 67(3):606-13. PubMed ID: 6325518
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
Chockalingam A; Zarlenga DS; Bannerman DD
Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
[TBL] [Abstract][Full Text] [Related]
39. Rational redesign of porcine pepsinogen containing an antimicrobial peptide.
Bryksa BC; Horimoto Y; Yada RY
Protein Eng Des Sel; 2010 Sep; 23(9):711-9. PubMed ID: 20601363
[TBL] [Abstract][Full Text] [Related]
40. Antibacterial peptides of bovine lactoferrin: purification and characterization.
Dionysius DA; Milne JM
J Dairy Sci; 1997 Apr; 80(4):667-74. PubMed ID: 9149961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
